Literature DB >> 28648301

Associations of Early Kidney Disease With Brain Magnetic Resonance Imaging and Cognitive Function in African Americans With Type 2 Diabetes Mellitus.

Barry I Freedman1, Kaycee M Sink2, Christina E Hugenschmidt2, Timothy M Hughes2, Jeff D Williamson2, Christopher T Whitlow3, Nicholette D Palmer4, Michael E Miller5, Laura C Lovato5, Jianzhao Xu4, S Carrie Smith4, Lenore J Launer6, Joshua I Barzilay7, Robert M Cohen8, Mark D Sullivan9, R Nick Bryan10, Benjamin C Wagner11, Donald W Bowden4, Joseph A Maldjian11, Jasmin Divers5.   

Abstract

BACKGROUND: Relationships between early kidney disease, neurocognitive function, and brain anatomy are poorly defined in African Americans with type 2 diabetes mellitus (T2DM). STUDY
DESIGN: Cross-sectional associations were assessed between cerebral anatomy and cognitive performance with estimated glomerular filtration rate (eGFR) and urine albumin-creatinine ratio (UACR) in African Americans with T2DM. SETTING & PARTICIPANTS: African Americans with cognitive testing and cerebral magnetic resonance imaging (MRI) in the African American-Diabetes Heart Study Memory in Diabetes (AA-DHS MIND; n=512; 480 with MRI) and Action to Control Cardiovascular Risk in Diabetes (ACCORD) MIND (n=484; 104 with MRI) studies. PREDICTORS: eGFR (CKD-EPI creatinine equation), spot UACR. MEASUREMENTS: MRI-based cerebral white matter volume (WMV), gray matter volume (GMV), and white matter lesion volume; cognitive performance (Mini-Mental State Examination, Digit Symbol Coding, Stroop Test, and Rey Auditory Verbal Learning Test). Multivariable models adjusted for age, sex, body mass index, scanner, intracranial volume, education, diabetes duration, hemoglobin A1c concentration, low-density lipoprotein cholesterol concentration, smoking, hypertension, and cardiovascular disease were used to test for associations between kidney phenotypes and the brain in each study; a meta-analysis was performed.
RESULTS: Mean participant age was 60.1±7.9 (SD) years; diabetes duration, 12.1±7.7 years; hemoglobin A1c concentration, 8.3%±1.7%; eGFR, 88.7±21.6mL/min/1.73m2; and UACR, 119.2±336.4mg/g. In the fully adjusted meta-analysis, higher GMV associated with lower UACR (P<0.05), with a trend toward association with higher eGFR. Higher white matter lesion volume was associated with higher UACR (P<0.05) and lower eGFR (P<0.001). WMV was not associated with either kidney parameter. Higher UACR was associated with lower Digit Symbol Coding performance (P<0.001) and a trend toward association with higher Stroop interference; eGFR was not associated with cognitive tests. LIMITATIONS: Cross-sectional; single UACR measurement.
CONCLUSIONS: In African Americans with T2DM, mildly high UACR and mildly low eGFR were associated with smaller GMV and increased white matter lesion volume. UACR was associated with poorer processing speed and working memory.
Copyright © 2017 National Kidney Foundation, Inc. All rights reserved.

Entities:  

Keywords:  African American; albuminuria; brain; chronic kidney disease (CKD); cognitive performance; estimated glomerular filtration rate (eGFR); magnetic resonance imaging (MRI); neurocognitive function; type 2 diabetes mellitus (T2DM); urine albumin-creatinine ratio (UACR)

Mesh:

Substances:

Year:  2017        PMID: 28648301      PMCID: PMC5651190          DOI: 10.1053/j.ajkd.2017.05.006

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  43 in total

1.  Albuminuria and cognitive decline in people with diabetes and normal renal function.

Authors:  Joshua I Barzilay; James F Lovato; Anne M Murray; Jeff Williamson; Faramaz Ismail-Beigi; Diane Karl; Vasilios Papademetriou; Lenore J Launer
Journal:  Clin J Am Soc Nephrol       Date:  2013-08-29       Impact factor: 8.237

2.  An image-processing system for qualitative and quantitative volumetric analysis of brain images.

Authors:  A F Goldszal; C Davatzikos; D L Pham; M X Yan; R N Bryan; S M Resnick
Journal:  J Comput Assist Tomogr       Date:  1998 Sep-Oct       Impact factor: 1.826

3.  White matter hyperintensities and their penumbra lie along a continuum of injury in the aging brain.

Authors:  Pauline Maillard; Evan Fletcher; Samuel N Lockhart; Alexandra E Roach; Bruce Reed; Dan Mungas; Charles DeCarli; Owen T Carmichael
Journal:  Stroke       Date:  2014-04-29       Impact factor: 7.914

4.  Kidney dysfunction and cognitive decline in women.

Authors:  Imran Sajjad; Francine Grodstein; Jae H Kang; Gary C Curhan; Julie Lin
Journal:  Clin J Am Soc Nephrol       Date:  2012-01-12       Impact factor: 8.237

5.  Kidney function and microstructural integrity of brain white matter.

Authors:  Sanaz Sedaghat; Lotte G M Cremers; Marius de Groot; Ewout J Hoorn; Albert Hofman; Aad van der Lugt; Oscar H Franco; Meike W Vernooij; Abbas Dehghan; M Arfan Ikram
Journal:  Neurology       Date:  2015-06-17       Impact factor: 9.910

6.  Intracranial deep white matter lesions (DWLs) are associated with chronic kidney disease (CKD) and cognitive impairment: a 5-year follow-up magnetic resonance imaging (MRI) study.

Authors:  N Kuriyama; T Mizuno; Y Ohshima; K Yamada; E Ozaki; M Shigeta; S Mitani; M Kondo; S Matsumoto; K Takeda; M Nakagawa; Y Watanabe
Journal:  Arch Gerontol Geriatr       Date:  2011-12-15       Impact factor: 3.250

7.  Computer-assisted segmentation of white matter lesions in 3D MR images using support vector machine.

Authors:  Zhiqiang Lao; Dinggang Shen; Dengfeng Liu; Abbas F Jawad; Elias R Melhem; Lenore J Launer; R Nick Bryan; Christos Davatzikos
Journal:  Acad Radiol       Date:  2008-03       Impact factor: 3.173

8.  Brain atrophy in peritoneal dialysis and CKD stages 3-5: a cross-sectional and longitudinal study.

Authors:  Kazuhiko Tsuruya; Hisako Yoshida; Yusuke Kuroki; Masaharu Nagata; Tohru Mizumasa; Koji Mitsuiki; Takashi Yoshiura; Makoto Hirakawa; Hidetoshi Kanai; Kei Hori; Hideki Hirakata; Takanari Kitazono
Journal:  Am J Kidney Dis       Date:  2014-09-11       Impact factor: 8.860

9.  Association of vascular risk factors with cognition in a multiethnic sample.

Authors:  Brooke C Schneider; Alden L Gross; Katherine J Bangen; Jeannine C Skinner; Andreana Benitez; M Maria Glymour; Bonnie C Sachs; Regina A Shih; Shannon Sisco; Jennifer J Manly; José A Luchsinger
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2014-05-12       Impact factor: 4.077

10.  Biomarkers of renal function and cognitive impairment in patients with diabetes.

Authors:  Anne M Murray; Joshua I Barzilay; James F Lovato; Jeff D Williamson; Michael E Miller; Santica Marcovina; Lenore J Launer
Journal:  Diabetes Care       Date:  2011-06-29       Impact factor: 19.112

View more
  12 in total

1.  HIV disease and diabetes interact to affect brain white matter hyperintensities and cognition.

Authors:  Minjie Wu; Omalara Fatukasi; Shaolin Yang; Jeffery Alger; Peter B Barker; Hoby Hetherington; Tae Kim; Andrew Levine; Eileen Martin; Cynthia A Munro; Todd Parrish; Ann Ragin; Ned Sacktor; Eric Seaberg; James T Becker
Journal:  AIDS       Date:  2018-08-24       Impact factor: 4.177

2.  Metabolic Biomarkers of Aging and Aging-related Diseases in Chinese Middle-Aged and Elderly Men.

Authors:  W Liu; Y Liu; Y Yang; W Ou; X Chen; B Huang; H Wang; M Liu
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

3.  White Matter Microstructure Changes and Cognitive Impairment in the Progression of Chronic Kidney Disease.

Authors:  Mengchen Liu; Yunfan Wu; Xixin Wu; Xiaofen Ma; Yi Yin; Huamei Fang; Sihua Huang; Huanhuan Su; Guihua Jiang
Journal:  Front Neurosci       Date:  2020-09-29       Impact factor: 4.677

4.  Vascular complications of diabetes: natural history and corresponding risks of dementia in a national cohort of adults with diabetes.

Authors:  Po-Yin Chang; I-T Ing Wang; Chern-En Chiang; Chen-Huan Chen; Wan-Yu Yeh; Victor W Henderson; Yi-Wen Tsai; Hao-Min Cheng
Journal:  Acta Diabetol       Date:  2021-02-23       Impact factor: 4.280

5.  Prevalence and Risk of Severe Cognitive Impairment in Advanced Chronic Kidney Disease.

Authors:  Christine M Burns; David S Knopman; David E Tupper; Cynthia S Davey; Yelena M Slinin; Kamakshi Lakshminarayan; Rebecca C Rossom; Sarah L Pederson; David T Gilbertson; Anne M Murray
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2018-03-02       Impact factor: 6.053

6.  Relationship Between Type 2 Diabetes and White Matter Hyperintensity: A Systematic Review.

Authors:  Dan-Qiong Wang; Lei Wang; Miao-Miao Wei; Xiao-Shuang Xia; Xiao-Lin Tian; Xiao-Hong Cui; Xin Li
Journal:  Front Endocrinol (Lausanne)       Date:  2020-12-21       Impact factor: 5.555

Review 7.  Albuminuria as a risk factor for mild cognitive impairment and dementia-what is the evidence?

Authors:  Boris Bikbov; Maria José Soler; Vesna Pešić; Giovambattista Capasso; Robert Unwin; Matthias Endres; Giuseppe Remuzzi; Norberto Perico; Ron Gansevoort; Francesco Mattace-Raso; Annette Bruchfeld; Andreja Figurek; Gaye Hafez
Journal:  Nephrol Dial Transplant       Date:  2021-12-28       Impact factor: 5.992

8.  Association of sickle cell trait with measures of cognitive function and dementia in African Americans.

Authors:  Nemin Chen; Christina Caruso; Alvaro Alonso; Vimal K Derebail; Abhijit V Kshirsagar; A Richey Sharrett; Nigel S Key; Rebecca F Gottesman; Megan L Grove; Jan Bressler; Eric Boerwinkle; B Gwen Windham; Thomas H Mosley; Hyacinth I Hyacinth
Journal:  eNeurologicalSci       Date:  2019-07-22

Review 9.  Review of the structural and functional brain changes associated with chronic kidney disease.

Authors:  M Michna; L Kovarova; A Valerianova; H Malikova; J Weichet; J Malik
Journal:  Physiol Res       Date:  2020-11-02       Impact factor: 1.881

Review 10.  Diabetes, Albuminuria and the Kidney-Brain Axis.

Authors:  Diana Maria Ariton; Joan Jiménez-Balado; Olga Maisterra; Francesc Pujadas; María José Soler; Pilar Delgado
Journal:  J Clin Med       Date:  2021-05-27       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.